Formulary
If you would like a medicine or device to be added to the Joint Formularies please get in touch with us via blmkicb.medsopt@nhs.net
Application forms can be downloaded below:
- Download the BLMK APC Formulary Subgroup Full Application Form – For new additions to the Formulary
- Download The BLMK APC Formulary Subgroup request for amendment to the Formularies form – For amendments to existing medicines and devices
Applications should normally be submitted 6 to 8 weeks before the meeting, whenever possible. See below for meeting dates.
Other useful forms:
- BLMK Declaration of Interests Form
- Shared Care Guidance BLMK master template
- BLMK Agenda cover sheet for Shared Care guidance
Dates of 2025 subgroup meetings:
- Tuesday 11th November 2025
Formulary SubGroup Meeting Papers
2025:
- BLMK Fomulary Subgroup Minutes November 2025
- BLMK Formulary Subgroup Minutes September 2025
- BLMK Formulary Subgroup Minutes June 2025
- BLMK Formulary Subgroup Minutes April 2025
- BLMK Formulary Subgroup Minutes February 2025
- BLMK Formulary Subgroup Minutes November 2024
2024:
- BLMK Formulary Subgroup Minutes September 2024
- BLMK Formulary Subgroup Minutes June 2024
- BLMK Formulary Subgroup Minutes April 2024
- BLMK Formulary Subgroup Minutes Feb 2024
2023:
- BLMK Formulary Subgroup Minutes November 2023
- BLMK Formulary Subgroup Minutes September 2023
- BLMK Formulary Subgroup Minutes June 2023
- BLMK Formulary Subgroup Minutes April 2023
- BLMK Formulary Subgroup Minutes February 2023
2022:
- BLMK Formulary Subgroup Minutes November 2022
- BLMK Formulary Subgroup Minutes September 2022
- BLMK Formulary Subgroup Minutes June 2022
- BLMK Formulary Subgroup Minutes April 2022
Practitioners are expected to use dressings that are listed in the Formulary or to have a valid rationale if another is chosen.
Applications for dressings to be added to the Formulary are accepted from Practitioners who work in the constituent organisations.
Applications are required to make the case that a new addition is:
- cost-effective
- an advantage over existing products
Please contact blmkicb.medsopt@nhs.net for a proposal form.
April 2026 – UPDATE
NHS Central East Integrated Care Board (ICB) was formed on 1 April 2026 and is the successor ICB to NHS Bedfordshire, Luton and Milton Keynes ICB, NHS Cambridgeshire and Peterborough ICB and the Hertfordshire part of NHS Hertfordshire and West Essex ICB. NHS Central East ICB had transferred to it the property, rights and liabilities of the predecessor organisations.
The actions and decisions of the predecessor organisation, including relevant clinical commissioning policies, relevant prescribing decisions and recommendations and relevant clinical pathways continue in effect. There are differences in places between some clinical commissioning policies, prescribing recommendations and pathways from the predecessor ICBs.
Clinical policies transferred to NHS Central East ICB from each of the relevant predecessor ICBs remain applicable to each part of the population for who they were originally created. These different policies will continue to apply to the relevant populations unless or until any new policy is adopted by the NHS Central East ICB (after public involvement if required).
We are in the process of developing a new NHS Central East ICB website for clinical commissioning policies, pathways and prescribing information. During this transition period, clinicians, providers, patients and the public can continue to access all legacy policies, prescribing recommendations, and pathways via the legacy ICB websites. Where legacy policies are superseded by new NHS Central East ICB policies, this will be clearly indicated on the relevant legacy policy and published on the new Central East website in advance of implementation.
If you have any questions or concerns do continue to contact your local teams at:
Hertfordshire and West Essex ICB ifr.hweicb@nhs.net
Bedfordshire, Luton and Milton Keynes ICB Blmkicb.ifrservice@nhs.net
Cambridge and Peterborough ICB cpicb.clinpolicies@nhs.net